207 related articles for article (PubMed ID: 18389421)
1. Long-term outcome of patients with dysthymia and panic disorder: a naturalistic 9-year follow-up study.
Svanborg C; Wistedt AA; Svanborg P
Nord J Psychiatry; 2008; 62(1):17-24. PubMed ID: 18389421
[TBL] [Abstract][Full Text] [Related]
2. Helpful and hindering factors for remission in dysthymia and panic disorder at 9-year follow-up: a mixed methods study.
Svanborg C; Bäärnhielm S; Aberg Wistedt A; Lützen K
BMC Psychiatry; 2008 Jul; 8():52. PubMed ID: 18590579
[TBL] [Abstract][Full Text] [Related]
3. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
Simon NM; Otto MW; Worthington JJ; Hoge EA; Thompson EH; Lebeau RT; Moshier SJ; Zalta AK; Pollack MH
J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
[TBL] [Abstract][Full Text] [Related]
4. The undertreatment of dysthymia.
Shelton RC; Davidson J; Yonkers KA; Koran L; Thase ME; Pearlstein T; Halbreich U
J Clin Psychiatry; 1997 Feb; 58(2):59-65. PubMed ID: 9062374
[TBL] [Abstract][Full Text] [Related]
5. What is the effect on comorbid personality disorder of brief panic-focused psychotherapy in patients with panic disorder?
Keefe JR; Milrod BL; Gallop R; Barber JP; Chambless DL
Depress Anxiety; 2018 Mar; 35(3):239-247. PubMed ID: 29212135
[TBL] [Abstract][Full Text] [Related]
6. Severity of panic disorder, adverse events in childhood, dissociation, self-stigma and comorbid personality disorders Part 2: Therapeutic effectiveness of a combined cognitive behavioural therapy and pharmacotherapy in treatment-resistant inpatients.
Kolek A; Prasko J; Ociskova M; Holubova M; Vanek J; Grambal A; Slepecky M
Neuro Endocrinol Lett; 2019 Dec; 40(6):271-283. PubMed ID: 32200586
[TBL] [Abstract][Full Text] [Related]
7. Influence of personality disorder on the treatment of panic disorder--comparison study.
Prasko J; Houbová P; Novák T; Záleský R; Espa-Cervená K; Pasková B; Vyskocilová J
Neuro Endocrinol Lett; 2005 Dec; 26(6):667-74. PubMed ID: 16380683
[TBL] [Abstract][Full Text] [Related]
8. Cognitive-behavioral group therapy for panic disorder in the general clinical setting: a naturalistic study with 1-year follow-up.
Martinsen EW; Olsen T; Tønset E; Nyland KE; Aarre TF
J Clin Psychiatry; 1998 Aug; 59(8):437-42; quiz 443. PubMed ID: 9721829
[TBL] [Abstract][Full Text] [Related]
9. Clinical issues in the long-term treatment of panic disorder.
Rosenbaum JF; Pollack MH; Pollock RA
J Clin Psychiatry; 1996; 57 Suppl 10():44-8; discussion 49-50. PubMed ID: 8917131
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of panic disorder in older patients.
Flint AJ; Gagnon N
Drugs Aging; 2003; 20(12):881-91. PubMed ID: 14565781
[TBL] [Abstract][Full Text] [Related]
11. Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination.
Maddux RE; Riso LP; Klein DN; Markowitz JC; Rothbaum BO; Arnow BA; Manber R; Blalock JA; Keitner GI; Thase ME
J Affect Disord; 2009 Oct; 117(3):174-9. PubMed ID: 19217168
[TBL] [Abstract][Full Text] [Related]
12. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management.
Haykal RF; Akiskal HS
J Clin Psychiatry; 1999 Aug; 60(8):508-18. PubMed ID: 10485632
[TBL] [Abstract][Full Text] [Related]
13. Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder.
Berger P; Sachs G; Amering M; Holzinger A; Bankier B; Katschnig H
J Affect Disord; 2004 May; 80(1):75-8. PubMed ID: 15094260
[TBL] [Abstract][Full Text] [Related]
14. The impact of panic-agoraphobic comorbidity on suicidality in hospitalized patients with major depression.
Brown LA; Gaudiano BA; Miller IW
Depress Anxiety; 2010 Mar; 27(3):310-5. PubMed ID: 20099269
[TBL] [Abstract][Full Text] [Related]
15. The issue of comorbidity in the treatment of panic.
Dunner DL
Int Clin Psychopharmacol; 1998 Apr; 13 Suppl 4():S19-24. PubMed ID: 9690961
[TBL] [Abstract][Full Text] [Related]
16. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
[TBL] [Abstract][Full Text] [Related]
17. Management of treatment-refractory panic disorder.
Mathew SJ; Coplan JD; Gorman JM
Psychopharmacol Bull; 2001; 35(2):97-110. PubMed ID: 12397890
[TBL] [Abstract][Full Text] [Related]
18. Comorbid personality disorders in subjects with panic disorder: do personality disorders increase clinical severity?
Ozkan M; Altindag A
Compr Psychiatry; 2005; 46(1):20-6. PubMed ID: 15714190
[TBL] [Abstract][Full Text] [Related]
19. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.
Russell JM; Kornstein SG; Shea MT; McCullough JP; Harrison WM; Hirschfeld RM; Keller MB
J Clin Psychiatry; 2003 May; 64(5):554-61. PubMed ID: 12755659
[TBL] [Abstract][Full Text] [Related]
20. Do comorbid personality disorders moderate panic-focused psychotherapy? An exploratory examination of the American Psychiatric Association practice guideline.
Milrod BL; Leon AC; Barber JP; Markowitz JC; Graf E
J Clin Psychiatry; 2007 Jun; 68(6):885-91. PubMed ID: 17592913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
